Mitogen-induced defective mitosis transforms neural progenitor cells
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noad082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Hiba K Omairi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Neural Stem Cells, Glioblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Terry Fox Research Institute and Foundation, Alberta Innovates.
Abstract (Originalsprache)
Background
Chromosome instability (CIN) with recurrent copy number alterations is a feature of many solid tumors, including glioblastoma (GBM), yet the genes that regulate cell division are rarely mutated in cancers. Here, we show that the brain-abundant mitogen, platelet-derived growth factor-A (PDGFA) fails to induce the expression of kinetochore and spindle assembly checkpoint genes leading to defective mitosis in neural progenitor cells (NPCs).
Methods
Using a recently reported in vitro model of the initiation of high-grade gliomas from murine NPCs, we investigated the immediate effects of PDGFA exposure on the nuclear and mitotic phenotypes and patterns of gene and protein expression in NPCs, a putative GBM cell of origin.
Results
NPCs divided abnormally in defined media containing PDGFA with P53-dependent effects. In wild-type cells, defective mitosis was associated with P53 activation and cell death, but in some null cells, defective mitosis was tolerated. Surviving cells had unstable genomes and proliferated in the presence of PDGFA accumulating random and clonal chromosomal rearrangements. The outcome of this process was a population of tumorigenic NPCs with recurrent gains and losses of chromosomal regions that were syntenic to those recurrently gained and lost in human GBM. By stimulating proliferation without setting the stage for successful mitosis, PDGFA-transformed NPCs lacking P53 function.
Conclusions
Our work describes a mechanism of transformation of NPCs by a brain-associated mitogen, raising the possibility that the unique genomic architecture of GBM is an adaptation to defective mitosis that ensures the survival of affected cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
- Canada's Michael Smith Genome Sciences Centre and BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
- Departments of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
- Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: John Gregory Cairncross
Förderung
- CIHR
- Terry Fox Research Institute and Foundation
- Alberta Innovates
- Alberta Cancer Foundation
- Alberta Children’s Hospital Foundation
- Genome BC, Genome Canada
- Cancer Research Society
- Canadian Institutes of Health Research
Zitieren
APA
Omairi, H. K., Grisdale, C. J., Meode, M., Bohm, A. K., Black, S., Adam, N. J., Chapman, C. P., Maroilley, T., Kelly, J. J., Tarailo-Graovac, M., Jones, S. J. M., Blough, M. D., & Cairncross, J. G. (2023). Mitogen-induced defective mitosis transforms neural progenitor cells. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad082
Vancouver
Omairi HK, Grisdale CJ, Meode M, Bohm AK, Black S, Adam NJ, et al. Mitogen-induced defective mitosis transforms neural progenitor cells. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad082
BibTeX
@article{Omairi2023,
author = {Omairi, Hiba K and Grisdale, Cameron J and Meode, Mathieu and Bohm, Alexandra K and Black, Sophie and Adam, Nancy J and Chapman, Cassidy P and Maroilley, Tatiana and Kelly, John J and Tarailo-Graovac, Maja and Jones, Steven J M and Blough, Michael D and Cairncross, John Gregory},
title = {Mitogen-induced defective mitosis transforms neural progenitor cells},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noad082}
}
EUVIMED